Comparison between Chemcel Bio-tech IPO and Nu Tek India IPO.
Chemcel Bio-tech IPO is a Mainboard Bookbuilding IPO proposed to list at BSE while Nu Tek India IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Chemcel Bio-tech IPO is up to ₹22.08 Cr whereas the issue size of the Nu Tek India IPO is up to ₹86.40 Cr. The final issue price of Chemcel Bio-tech IPO is ₹16.00 per share and of Nu Tek India IPO is ₹192.00 per share.
| Chemcel Bio-tech IPO | Nu Tek India IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹170.00 per share | |
| Issue Price (Upper) | ₹192.00 per share | |
| Issue Price (Final) | ₹16.00 per share | ₹192.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹0.00 per share | ₹0.00 per share |
| Market Lot Size | 30 shares | |
| Fresh Issue Size | 1,38,00,206 shares | 35,00,000 shares |
| Fresh Issue Size (Amount) | up to ₹22.08 Cr | up to ₹67.20 Cr |
| OFS Issue Size | 0 shares | 10,00,000 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹19.20 Cr |
| Issue Size Total | 1,38,00,206 shares | 45,00,000 shares |
| Issue Size Total (Amount) | up to ₹22.08 Cr | up to ₹86.40 Cr |
Chemcel Bio-tech IPO opens on Sep 09, 2008, while Nu Tek India IPO opens on Jul 29, 2008. The closing date of Chemcel Bio-tech IPO and Nu Tek India IPO is Sep 12, 2008, and Aug 01, 2008, respectively.
| Chemcel Bio-tech IPO | Nu Tek India IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Sep 09, 2008 | Jul 29, 2008 |
| Issue Close | Sep 12, 2008 | Aug 01, 2008 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | Oct 13, 2008 | Aug 27, 2008 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Chemcel Bio-tech IPO P/E ratio is , as compared to Nu Tek India IPO P/E ratio of .
| Chemcel Bio-tech IPO | Nu Tek India IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 57.23 | 53.21 | ||||
| Promoter Shareholding (Post-Issue) | 29.4 | 42.42 | ||||
| P/E Ratio | ||||||
| Market Cap | ₹41.47 Cr. | ₹331.38 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW | 9.14 | 23.79 |
In the Chemcel Bio-tech IPO Retail Individual Investors (RII) are offered 64,00,000 shares while in Nu Tek India IPO retail investors are offered 64,00,000 shares. Qualified Institutional Buyers (QIB) are offered in Chemcel Bio-tech IPO and 22,00,000 shares in Nu Tek India IPO.
| Chemcel Bio-tech IPO | Nu Tek India IPO | |
|---|---|---|
| Anchor Investor Reservation | ||
| Market Maker Reservation | ||
| QIB | 22,00,000 shares | |
| NII | 64,00,000 shares | 6,60,000 shares |
| RII | 64,00,000 shares | 15,40,000 shares |
| Employee | 10,00,000 shares | 1,00,000 shares |
| Others | ||
| Total | 1,38,00,000 shares | 45,00,000 shares |
Chemcel Bio-tech IPO subscribed 1.70x in total, whereas Nu Tek India IPO subscribed 1.63x.
| Chemcel Bio-tech IPO | Nu Tek India IPO | |
|---|---|---|
| QIB (times) | 2.06x | |
| NII (times) | 1.06x | 1.78x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 2.59x | 1.01x |
| Employee (times) | 0.03x | 0.96x |
| Other (times) | ||
| Total (times) | 1.70x | 1.63x |
